1. Pharmacology of drugs that alter multidrug resistance in cancer;Ford;Pharmacol. Rev.,1990
2. Circumvention of adriamycin resistance by dipyridamole analogues: a structure–activity relationship study;Ramu;Int. J. Cancer,1989
3. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells;Zhen;Oncol. Res.,1992
4. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport;Chen;Cancer Res.,1993
5. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro;Shalinsky;Cancer Res.,1990